Cdkn2a Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Cdkn2a
cyclin dependent kinase inhibitor 2A
MGI:104738

77 phenotypes from 17 alleles in 19 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cdkn2a^em1Cjs/Cdkn2a^em1Cjs B6.Cg-Cdkn2a^em1Cjs	increased acute lymphoblastic leukemia incidence	J:244260
	increased testis weight	J:244260
	normal reproductive system phenotype	J:244260
	normal vision/eye phenotype	J:244260
Cdkn2a^em2Cjs/Cdkn2a^em2Cjs C57BL/6-Cdkn2a^em2Cjs	abnormal spermatocyte morphology	J:244260
	binocular blindness	J:244260
	normal neoplasm	J:244260
	oligozoospermia	J:244260
	persistent hyperplastic primary vitreous	J:244260
	retina detachment	J:244260
Cdkn2a^Pctr1-DBA/2N/? involves: BALB/cAnPt * DBA/2N	decreased tumor incidence	J:16958
Cdkn2a^tm1(GFP)Cjs/Cdkn2a^tm1(GFP)Cjs involves: 129S1/Sv * C57BL/6	increased gastrointestinal stromal tumor incidence	J:87339
	increased hemangiosarcoma incidence	J:87339
	increased histiocytic sarcoma incidence	J:87339
	increased incidence of tumors by ionizing radiation induction	J:87339
	increased lymphoma incidence	J:87339
	increased sarcoma incidence	J:87339
	increased tumor incidence	J:87339
Cdkn2a^tm1.1Brn/Cdkn2a^tm1.1Brn involves: 129P2/OlaHsd * FVB/N	decreased incidence of tumors by chemical induction	J:125189
	normal neoplasm	J:71393
Cdkn2a^tm1.1Gsu/Cdkn2a^tm1.1Gsu Tg(Pdx1-cre)6Tuv/0 involves: 129S4/SvJaeSor * C57BL/6J * FVB/N	normal neoplasm	J:198619
Cdkn2a^{tm1a(EUCOMM)Wtsi}/Cdkn2a^{tm1a(EUCOMM)Wtsi} C57BL/6N-Cdkn2a^{tm1a(EUCOMM)Wtsi}/Wtsi	abnormal lens morphology	J:175295
	cataract	J:175295
Cdkn2a^tm1Cjs/Cdkn2a⁺ involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd	increased carcinoma incidence	J:93298
	increased incidence of tumors by chemical induction	J:93298
	increased papilloma incidence	J:93298
Cdkn2a^tm1Cjs/Cdkn2a^tm1Cjs involves: 129X1/SvJ	blindness	J:147752
	decreased testis weight	J:147752
	oligozoospermia	J:147752
	testicular atrophy	J:147752
Cdkn2a^tm1Cjs/Cdkn2a^tm1Cjs involves: 129X1/SvJ * C57BL/6	abnormal cell physiology	J:44427
	abnormal lens capsule morphology	J:75215
	abnormal lens morphology	J:75215
	abnormal retina ganglion layer morphology	J:75215
	abnormal retina inner nuclear layer morphology	J:75215
	abnormal retina morphology	J:75215
	abnormal retina photoreceptor morphology	J:75215
	abnormal spermatocyte morphology	J:244260
	binocular blindness	J:244260
	decreased testis weight	J:244260
	increased acute lymphoblastic leukemia incidence	J:244260
	increased carcinoma incidence	J:44427
	increased fibroblast proliferation	J:44427
	increased fibrohistocytoma incidence	J:44427
	increased fibrosarcoma incidence	J:44427
	increased incidence of tumors by chemical induction	J:44427
	increased incidence of tumors by ionizing radiation induction	J:44427
	increased lymphoma incidence	J:44427
	increased T cell derived lymphoma incidence	J:44427
	increased tumor incidence	J:44427
	microphthalmia	J:75215
	oligozoospermia	J:244260
	persistent hyperplastic primary vitreous	J:75215, J:149526
	primary vitreous hyperplasia	J:101016
	retina detachment	J:75215, J:244260
	retina fold	J:75215
	normal vision/eye phenotype	J:149526
Cdkn2a^tm1Cjs/Cdkn2a^tm1Cjs involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd	increased carcinoma incidence	J:93298
	increased incidence of tumors by chemical induction	J:93298
	increased metastatic potential	J:93298
	increased papilloma incidence	J:93298
	increased squamous cell carcinoma incidence	J:93298
	increased tumor growth/size	J:93298
Cdkn2a^tm1Nesh/Cdkn2a^tm1Nesh involves: 129S6/SvEvTac * FVB/N	abnormal cell physiology	J:88365
	hindlimb paralysis	J:88365
	increased incidence of tumors by chemical induction	J:88365
	increased lung carcinoma incidence	J:88365
	increased osteosarcoma incidence	J:88365
	increased sarcoma incidence	J:88365
	increased small lymphocytic lymphoma incidence	J:88365
	increased tumor incidence	J:88365
	seizures	J:88365
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp FVB.Cg-Cdkn2a^tm1Rdp	abnormal lens development	J:110215
	abnormal posterior eye segment morphology	J:110215
	abnormal retina neuronal layer morphology	J:110215
	abnormal retina photoreceptor morphology	J:110215
	cataract	J:110215
	microphthalmia	J:110215
	persistent hyperplastic primary vitreous	J:110215
	retina fold	J:110215
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp involves: 129/Sv * C57BL/6 * C57BL/6J * SJL	abnormal cell physiology	J:72780
	abnormal keratinocyte physiology	J:72780
	abnormal skin physiology	J:72780
	delayed cellular replicative senescence	J:72780
	increased squamous cell carcinoma incidence	J:72780
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp involves: 129/Sv * C57BL/6 * SJL	abnormal cell cycle	J:53805
	abnormal spleen morphology	J:53805
	abnormal spleen red pulp morphology	J:53805
	extramedullary hematopoiesis	J:53805
	increased B cell derived lymphoma incidence	J:53805
	increased cutaneous melanoma incidence	J:98545
	increased fibroblast proliferation	J:53805
	increased fibrosarcoma incidence	J:53805
	increased hemangiosarcoma incidence	J:53805
	increased sarcoma incidence	J:53805
	increased spleen white pulp amount	J:53805
	increased tumor incidence	J:53805
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp involves: 129/Sv * C57BL/6J * FVB/N * SJL	abnormal cell physiology	J:88365
	decreased tumor-free survival time	J:88365
	increased lymphoma incidence	J:88365
	increased sarcoma incidence	J:88365
	increased tumor incidence	J:88365
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp involves: 129/Sv * C57BL/6J * SJL	increased brain tumor incidence	J:163931
Cdkn2a^tm1Sxs/Cdkn2a^tm1Sxs involves: 129/Sv * C57BL/6	abnormal eye morphology	J:149526
	abnormal tumor incidence	J:149526
	primary vitreous hyperplasia	J:149526
Cdkn2a^tm2.1Brn/Cdkn2a^tm2.1Brn involves: 129P2/OlaHsd * FVB/N	increased carcinoma incidence	J:71393
	increased incidence of tumors by chemical induction	J:71393
	increased lymphoma incidence	J:71393
	increased melanoma incidence	J:71393
	increased metastatic potential	J:71393
	increased sarcoma incidence	J:71393
	increased tumor incidence	J:71393
Cdkn2a^tm2.1Rdp/Cdkn2a⁺ involves: 129S6/SvEvTac * FVB/N	increased tumor incidence	J:71394
Cdkn2a^tm2.1Rdp/Cdkn2a^tm2.1Rdp involves: 129S6/SvEvTac * FVB/N	increased CD4-positive, alpha-beta T cell number	J:71394
	increased CD8-positive, alpha-beta T cell number	J:71394
	increased double-positive T cell number	J:71394
	increased incidence of tumors by chemical induction	J:71394, J:88365
	increased lymphoma incidence	J:88365
	increased osteosarcoma incidence	J:88365
	increased sarcoma incidence	J:88365
	increased small lymphocytic lymphoma incidence	J:88365
	increased splenocyte proliferation	J:71394
	increased thymus weight	J:71394
	increased tumor incidence	J:71394, J:88365
	thymus hyperplasia	J:71394
Cdkn2a^tm3(cre)Cjs/Cdkn2a⁺ involves: 129S1/Sv * C57BL/6	male infertility	J:147752
Cdkn2a^tm3(cre)Cjs/Cdkn2a^tm4Cjs involves: 129S1/Sv * C57BL/6	abnormal lens morphology	J:147752
	abnormal retina morphology	J:147752
	blindness	J:147752
	microphthalmia	J:147752
	retina fold	J:147752
Cdkn2a^tm4Cjs/Cdkn2a^tm4Cjs involves: 129S1/Sv * C57BL/6	normal neoplasm	J:147752
Cdkn2a^tm4Rdp/Cdkn2a^tm4Rdp Tg(Pdx1-cre)89.1Dam/0 involves: C57BL/6 * CBA * FVB/N	normal neoplasm	J:87196
Tg(TTR-p19Cdkn2a)2Tvd/0 involves: C57BL/6J * DBA/2J	increased circulating glucose level	J:94077
	polydipsia	J:94077
	polyuria	J:94077
	reduced female fertility	J:94077

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24